STOCKHOLDERS' EQUITY (Tables)

12 Months Ended

Jun. 30, 2021

Equity [Abstract]

Summary of Changes in Accumulated Other Comprehensive Income (Loss)

The following table presents the changes in accumulated other comprehensive loss (“AOCL”):

	Fiscal Year Ended June 30,
	2021		2020
Foreign currency translation adjustments:
Other comprehensive income (loss) before reclassifications (1)	$	85,581	$	(37,847)
Amounts reclassified into income (2)	16,073		95,120
Deferred (losses) gains on cash flow hedging instruments:
Amount of loss recognized in AOCL on derivatives	(810)		(1,413)
Amount of loss reclassified from AOCL into expense (3)	1,290		617
Deferred losses on net investment hedging instruments:
Amount of loss recognized in AOCL on derivatives	(3,359)		(2,788)
Amount of gain reclassified from AOCL into income (4)	(394)		(77)
Net change in AOCL	$	98,381	$	53,612

(1)Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature and were $0 and a loss of $898 for the fiscal years ended June 30, 2021 and 2020, respectively.

(2)Foreign currency translation gains or losses of foreign subsidiaries related to divested businesses are reclassified into income once the liquidation of the respective foreign subsidiaries is substantially complete. At the completion of the sales of Danival, Fruit and GG UniqueFiber®, the Company reclassified $16,073 of translations from AOCL to the Company's results of operations. At the completion of the sale of Tilda, the Company reclassified $95,120 of translation losses from Accumulated comprehensive loss to the Company’s results of discontinued operations.

(3)Amounts reclassified into income for deferred gains (losses) on cash flow hedging instruments are recorded in the Consolidated Statements of Operations as follows:

	Fiscal Year Ended June 30,
	2021		2020
Cost of sales	$	68	$	103
Interest and other financing expense, net	(150)		$	72
Other expense (income), net	$	(1,556)	$	(959)

(4)Amounts reclassified into income for deferred losses on net investment hedging instruments are recognized in “Interest and other financing expense, net” in the Consolidation Statements of Operations and were $498 and $98 for the fiscal years ended June 30, 2021 and 2020, respectively